Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05868122 · ClinicalTrials.gov registry record · Phase 3
A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following Bunionectomy
A Phase 3 study, sponsored by Johnson & Johnson Consumer Inc. (J&JCI).
- Completed
- Registry status
- Phase 3
- Development phase
- 143
- Enrollment target
NCT05868122 is a Phase 3 study that has completed, run by Johnson & Johnson Consumer Inc. (J&JCI). The registered enrollment target is 143 participants.
The verdict
NCT05868122, a Phase 3 study, has completed, sponsored by Johnson & Johnson Consumer Inc. (J&JCI).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 143 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate effectiveness of a fixed combination of acetaminophen/naproxen sodium compared with placebo for reduction of pain when administered as multiple doses over a 48-hour period.
Interventions
- DRUG Placebo
- DRUG Acetaminophen/Naproxen Sodium Fixed Combination
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 143 participants |
| Start Date | 2023-09-07 |
| Est. Completion | 2024-05-30 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05868122
The ClinicalTrials.gov registry entry for NCT05868122 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 143 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Consumer Inc. (J&JCI), which has 40 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05868122 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05868122 about?
NCT05868122 is a clinical study titled "A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following Bunionectomy". The purpose of this study is to evaluate effectiveness of a fixed combination of acetaminophen/naproxen sodium compared with placebo for reduction of pain when administered as multiple doses over a 48-hour period.
What is the current status of trial NCT05868122?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 143 participants. The study started on 2023-09-07. Estimated completion is 2024-05-30.
What interventions are being tested in trial NCT05868122?
The interventions under investigation include: Placebo (DRUG), Acetaminophen/Naproxen Sodium Fixed Combination (DRUG).
Who is sponsoring clinical trial NCT05868122?
This trial is sponsored by Johnson & Johnson Consumer Inc. (J&JCI), which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.